They had BTD so priority review was a given. GSK has a PDUFA date a few weeks earlier for their candidate (got priority review without having BTD). Clearly both are being set up for approval in time for the June ACIP meeting which will be the more significant milestone for both vaccines IMO given approval is almost a given
Market Data 
Markets 
AI
